This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: None, Subject name: Pharmacology
[{'content': 'True about zafirlukast is : \nSelect and explain. \nA. It inhibit lipooxygenase pathway, B. It blocks LT receptor, C. It can be administered orally, D. All of these', 'role': 'user'}, {'content': 'Answer: D \nExplanation: Zafirlukast and montelukast are cysteinyl leukotriene receptor antagonists. They cause modest improvement in lung function and reduction in asthma symptoms and lessen the need for beta-agonist rescue therapy. These drugs can be considered as alternatives to low-dose inhaled corticosteroids in patients with persistent asthma.\nZafirlukast is long-acting and can be given twice to once daily orally. It is a modest bronchodilator that reduces asthma morbidity, provides protection against exercise-induced asthma and diminishes nocturnal symptoms.\nThese are less effective than corticosteroids.', 'role': 'assistant'}]